Page 2 - கிலியட் அறிவியல் இன்க் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிலியட் அறிவியல் இன்க் ஆன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிலியட் அறிவியல் இன்க் ஆன் Today - Breaking & Trending Today

Gilead forecasts 2021 growth, strong remdesivir COVID-19 sales

3 Min Read
(Reuters) - Gilead Sciences Inc on Thursday forecast its 2021 results above Wall Street estimates after posting a 26% rise in fourth-quarter 2020 revenue, driven by sales of its antiviral drug, remdesivir, which is used to treat COVID-19 patients.
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
Shares of Gilead were up 2.5% in extended trading.
Gilead said the COVID-19 pandemic continues to affect its sales, including its treatments for hepatitis C and HIV, due to fewer people going to their doctors. It expects a gradual recovery in underlying market dynamics starting the second quarter of this year. ....

United States , Karishma Singh , Michael Yee , Vishwadha Chander , Merdad Parsey , Thomson Reuters Trust Principles , Gilead Sciences Inc On , Sciences Inc , Wall Street , Chief Medical Officer Merdad Parsey , Anild Silva , Thomson Reuters Trust , Bio Therapeutic Drugs Trbc Level 5 , Content Produced In Bangalore , Company News , Healthcare Trbc Level 1 , Biotechnology Amp Medical Research Trbc Level 4 , Major News , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Performance Results Earnings , Results Forecasts Warnings , Reuters Top News , ஒன்றுபட்டது மாநிலங்களில் , கரிஷ்மா சிங் , மைக்கேல் யீ ,

Gilead forecasts 2021 growth, strong remdesivir COVID-19 sales - Netscape Money & Business

Gilead forecasts 2021 growth, strong remdesivir COVID-19 sales - Netscape Money & Business
netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.

United States , Karishma Singh , Michael Yee , Deena Beasley , Vishwadha Chander , Merdad Parsey , Gilead Sciences Inc On , Sciences Inc , Wall Street , Chief Medical Officer Merdad Parsey , Anild Silva , ஒன்றுபட்டது மாநிலங்களில் , கரிஷ்மா சிங் , மைக்கேல் யீ , தீனா பீஸ்லி , கிலியட் அறிவியல் இன்க் ஆன் , அறிவியல் இன்க் , சுவர் தெரு ,